United Therapeutics (UTHR) Inventory (2009 - 2026)

United Therapeutics has disclosed Inventory across 18 years of filings, most recently posting $178.3 million for Q1 2026.

• Inventory for Q1 2026 came in at $178.3 million, up 7.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $178.3 million (up 7.8% YoY), and the FY2025 annual result was $183.1 million, up 15.96% from the prior year.
• Inventory came in at $178.3 million for Q1 2026 at United Therapeutics, down from $183.1 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $183.1 million in Q4 2025 to a low of $88.2 million in Q1 2022.
• The 5-year median for Inventory is $120.2 million (2024), against an average of $131.0 million.
• Across the five-year window, Inventory retreated 5.89% in 2022 and jumped 41.23% in 2024, its largest moves.
• United Therapeutics' Inventory stood at $102.0 million in 2022, then increased by 9.61% to $111.8 million in 2023, then surged by 41.23% to $157.9 million in 2024, then advanced by 15.96% to $183.1 million in 2025, then slipped by 2.62% to $178.3 million in 2026.
• The last three Inventory figures came in at $178.3 million (Q1 2026), $183.1 million (Q4 2025), and $176.5 million (Q3 2025), per Business Quant data.